Michael Thomas Henderson, Chief Executive Officer of Apogee Therapeutics, Inc. (APGE), executed a significant sale of company stock on June 22, 2026. Henderson sold 80,000 shares at an average price of $132.54 per share, resulting in a total transaction value of approximately $10.60 million.
This transaction adds to a series of recent sales by Henderson and other Apogee executives. Carl Dambkowski also reported selling 26,400 shares on the same day, valued at roughly $3.50 million. While insider selling can occur for various reasons such as portfolio diversification or tax planning, it is noted that these transactions do not necessarily indicate a negative outlook for the company.